Genetically modified pseudoviruses
Offered at small and large scales to support preclinical and clinical development.
Source: LinkedIn company description · Retrieved October 13, 2026
Ivano Bioscience develops research tools intended to support vaccine and therapeutic discovery.
The company offers genetically modified pseudoviruses at small and large scales for preclinical and clinical development. The company aims to make biological systems reproducible, scalable, and accessible for research teams.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Offered at small and large scales to support preclinical and clinical development.
Source: LinkedIn company description · Retrieved October 13, 2026
The company is developing neutralizing detection assays, including a patent-pending kit for high-throughput screening in standard laboratory settings.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026 and September 27, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.